The need to re-evaluate premenstrual syndromes became apparent in 1997-1998
and early 1999. The success stories of some symptomatic treatment modaliti
es and more sophisticated studies of pathobiology chart the pathways for fu
ture progress: the shift from a descriptive diagnosis to diagnoses based on
etiology, the recognition of diversified vulnerabilities and their express
ion in particular situations, and specific treatment modalities. (C) 1999 L
ippincott Wlliams & Wilkins.